PharmTech Europe News

EMA Denies Authorization of Duchenne Muscular Dystrophy Treatment, Again

October 18, 2024

The agency has reconfirmed its recommendation to not give positive opinion to Translarna (ataluren) after a reexamination of the available data.

Chiesi Launches Biotech Center of Excellence in Parma, Italy

October 15, 2024

The design of the center prioritizes integration of the entire supply chain, with the end goals of accelerating product development and autonomous production capacity in alignment with EU priorities.

EMA and HMA Publish Network Strategy for Public Consultation

October 11, 2024

The draft joint network strategy for the EU until 2028 will be open for public consultation until Nov. 30, 2024.

CMOs and Hybrid Companies Predicted to Hold 54% of Biologics Capacity in 2028, According to CPHI Annual Survey

October 08, 2024

According to the annual survey, four of the five biggest biologics capacity holders in 2028 will comprise CMOs, which are expected to have 45% of all CMO capacity in Asia.

Cellevate Plans Pre-Launch of First Nanofiber Microcarriers for Viral Vector Manufacturing at CPHI Milan

October 07, 2024

The nanofiber microcarriers are the first of their kind for manufacturing viral vectors used in gene therapy production, according to Cellevate.

SGD Pharma to Introduce Siliconized Molded Glass Vials at CPHI Milan to Showcase Sustainable Packaging

October 02, 2024

As part of a range of sustainable products and services that SGD Pharma plans to showcase at CPHI Milan, the company will introduce its siliconized molded glass vials.

Results from CPHI Milan Survey Find No Favor Among Industry for BIOSECURE Act While Predicting Faster Growth for CDMOs in 2025

September 27, 2024

According to the survey results, 49% of industry respondents are “highly positive” on the contract services sector seeing growth over the next 18 months.